Search
CorporateFactSheet-2021_EN_230320
Partnering in Cardiometabolic JAN 2023 Corporate
Partnering in CNS FEB 2023 Corporate
Partnering in Imm & Resp JAN 2023 Corporate
Partnering in RBB JAN 2023 Corporate
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Technologies JAN 2023 Corporate
Partnering in Biotherapeutics Technologies MARCH 2023 Corporate
Partnering in Oncology JAN 2023 Corporate
Partnering in Oncology JAN 2023 Corporate
Boehringer_Ingelheim_Corporate_Factsheet_2019.pdf
Corporate-Policy-on-Supply-Chain-Integrity_0.pdf
Boehringer_Ingelheim_Corporate_Factsheet.pdf
Ethics and Compliance
Consistent with the Core of our Leitbild and Code of Conduct, we act with integrity and are committed to conducting business in a lawful and ethical manner.
Fabio Paganini fostering inclusion & agility in AH
How employees are contributing to an inclusive culture at Boehringer Ingelheim.
TCO patient podcasts
From clinical trials to living with cancer, hear patient perspectives on different cancer topics in this podcast series.
History of the logo
Overview of the history of the corporate logo of Boehringer Ingelheim, from the founding years of the company until today
Building Lasting Partnerships for a Better Future
Working with the University of Georgia, we’ve co-created a sustainability training initiative that benefits people, animals and the planet.
Their dogs are their world
Corporate social responsibility in Brazil: Volunteer work and animal healthcare donations for homeless people and their pets.
Cristian Torreblanca
Cristian Torreblanca Estrada is a Corporate Global Facilities and Engineering Senior Manager Controller in Germany – with plans for growth across the global business.
Rahul Prasad
Rahul J. Prasad is a Senior Consultant with our Corporate Strategy & Consulting division – a job that suits his passion for data and his love of variety.
BIVF funding more than doubled to 250 M€
Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
Brazil boosts biosecurity in dairy farms
We partnered with Embrapa to help farmers and local authorities set best practices in biosecurity for dairy through a biosecurity certificate.
What we do
Boehringer Ingelheim is a multinational corporation with divisions dedicated to Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.